84 related articles for article (PubMed ID: 6769629)
1. Solubilization and concentration of a bone-inducing substance from a murine osteosarcoma.
Takaoka K; Ono K; Amitani K; Kishimoto R; Nakata Y
Clin Orthop Relat Res; 1980 May; (148):274-80. PubMed ID: 6769629
[TBL] [Abstract][Full Text] [Related]
2. Osteogenesis by factor(s) isolated from mouse osteosarcoma cells in combination with collagen.
Yasui N; Ochi T; Takaoka K; Ono K; Nakata Y
Biken J; 1980 Jun; 23(2):83-7. PubMed ID: 6936024
[TBL] [Abstract][Full Text] [Related]
3. Solubility of a bone-inducing substance from a murine osteosarcoma.
Yoshikawa H; Takaoka K; Shimizu N; Ono K
Clin Orthop Relat Res; 1984; (182):231-5. PubMed ID: 6581884
[TBL] [Abstract][Full Text] [Related]
4. Biochemical stability of a bone-inducing substance from murine osteosarcoma.
Yoshikawa H; Takaoka K; Shimizu N; Ono K; Nakata Y; Amitani K
Clin Orthop Relat Res; 1982 Mar; (163):248-53. PubMed ID: 6950822
[TBL] [Abstract][Full Text] [Related]
5. Partial purification of bone-inducing substances from a murine osteosarcoma.
Takaoka K; Yoshikawa H; Shimizu N; Ono K; Amitani K; Nakata Y
Clin Orthop Relat Res; 1982 Apr; (164):265-70. PubMed ID: 6950823
[TBL] [Abstract][Full Text] [Related]
6. Solubilized bone morphogenetic protein (BMP) from mouse osteosarcoma and rat demineralized bone matrix.
Hanamura H; Higuchi Y; Nakagawa M; Iwata H; Nogami H; Urist MR
Clin Orthop Relat Res; 1980 May; (148):281-90. PubMed ID: 6929747
[TBL] [Abstract][Full Text] [Related]
7. Establishment of transplantable murine osteosarcoma cell line with endochondral ossification.
Nishi T; Kusumi T; Tanaka M; Sato F; Sasaki M; Kudo H; Kijima H
Anticancer Res; 2008; 28(3A):1627-31. PubMed ID: 18630519
[TBL] [Abstract][Full Text] [Related]
8. Osteogenic induction by cell-free material from murine osteosarcoma and its cultured cell line.
Amitani K; Ono K; Sakamoto Y; Nakata Y
Gan; 1975 Jun; 66(3):327-9. PubMed ID: 810384
[TBL] [Abstract][Full Text] [Related]
9. Osteogenic potential of murine osteosarcoma cells: comparison of bone-specific gene expression in in vitro and in vivo conditions.
Gerstenfeld LC; Uporova T; Schmidt J; Strauss PG; Shih SD; Huang LF; Gundberg C; Mizuno S; Glowacki J
Lab Invest; 1996 May; 74(5):895-906. PubMed ID: 8642785
[TBL] [Abstract][Full Text] [Related]
10. Human osteosarcoma-derived soluble bone morphogenetic protein.
Bauer FC; Urist MR
Clin Orthop Relat Res; 1981; (154):291-5. PubMed ID: 6937275
[TBL] [Abstract][Full Text] [Related]
11. [A postoperative osteosarcoma recurrence after bone distraction by Ilizarov method in a dog].
Mitin VN; Solov'ev IuN; Iagnikov SA; Garanin DV; Iakunina MN
Arkh Patol; 1998; 60(4):44-6. PubMed ID: 9791695
[TBL] [Abstract][Full Text] [Related]
12. Solubilization and purification of bone morphogenetic protein (BMP) from Dunn osteosarcoma.
Hanamura H; Higuchi Y; Nakagawa M; Iwata H; Urist MR
Clin Orthop Relat Res; 1980; (153):232-40. PubMed ID: 6934861
[TBL] [Abstract][Full Text] [Related]
13. Differential histologic diagnosis of osteoid. A study on human osteosarcoma collagen by the histochemical picrosirius-polarization method.
Junqueira LC; Assis Figueiredo MT; Torloni H; Montes GS
J Pathol; 1986 Feb; 148(2):189-96. PubMed ID: 3456452
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of osteogenic factors associated with osteoinductivity of human osteosarcoma cell lines.
Yu Y; Harris RI; Yang JL; Anderson HC; Walsh WR
J Biomed Mater Res A; 2004 Jul; 70(1):122-8. PubMed ID: 15174116
[TBL] [Abstract][Full Text] [Related]
15. [Pathology of osteogenic sarcoma].
Solov'ev IuN
Arkh Patol; 1982; 44(7):83-6. PubMed ID: 6751299
[TBL] [Abstract][Full Text] [Related]
16. Comparison of human osteoblasts and osteogenic cells from heterotopic bone.
Kaysinger KK; Ramp WK; Lang GJ; Gruber HE
Clin Orthop Relat Res; 1997 Sep; (342):181-91. PubMed ID: 9308541
[TBL] [Abstract][Full Text] [Related]
17. Inhibition by tumor necrosis factor of induction of ectopic bone formation by osteosarcoma-derived bone-inducing substance.
Yoshikawa H; Hashimoto J; Masuhara K; Takaoka K; Ono K
Bone; 1988; 9(6):391-6. PubMed ID: 3150288
[TBL] [Abstract][Full Text] [Related]
18. Tumor bone formation in different osteosarcomas: topological, biochemical, and histochemical analyses.
Althoff J; Quint P; Höhling HJ; Roessner A; Grundmann E
Curr Top Pathol; 1989; 80():55-89. PubMed ID: 2776496
[No Abstract] [Full Text] [Related]
19. PEDF-derived synthetic peptides exhibit antitumor activity in an orthotopic model of human osteosarcoma.
Ek ET; Dass CR; Contreras KG; Choong PF
J Orthop Res; 2007 Dec; 25(12):1671-80. PubMed ID: 17600821
[TBL] [Abstract][Full Text] [Related]
20. Fates and osteogenic differentiation potential of human mesenchymal stem cells in immunocompromised mice.
Xia Z; Locklin RM; Triffitt JT
Eur J Cell Biol; 2008 Jun; 87(6):353-64. PubMed ID: 18417247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
